1. Zamani SG. Therapeutic cloning and the right to health in international human rights law. Public Law Researsh. 2006;8(19):25–41. [Persian] [
Article]
2. Niavarani S, Javid E. The right to access to essential drugs within the framework of TRIPS agreement and the challenge of protection of international human right to health. International Law Review. 2016;33(54):29–58. [Persian] [
DOI]
3. Alekajbaf H. Concept and situation of Rights to Health under the International Human Rights bills”. Iranian Journal of Medical Law. 2013;7(24):139–70. [Persian] [
Article]
4. Sadeghi M.Protection of Pharmaceutical. Tehran: Mizan Publication; 2008, pp:136. [Persian]
5. Beiter KD. Establishing Conformity between TRIPS and Human Rights: Hierarchy in International Law, Human Rights Obligations of the WTO and Extraterritorial State Obligations Under the International Covenant on Economic, Social and Cultural Rights. In: Ullrich H, Hilty RM, Lamping M, Drexl J, editors. TRIPS plus 20: From Trade Rules to Market Principles. Berlin, Heidelberg: Springer; 2016, pp: 499. [
DOI]
6. Wallot M. The Proportionality Principle in the TRIPS Agreement. In: Ullrich H, Hilty RM, Lamping M, Drexl J, editors. TRIPS plus 20: From Trade Rules to Market Principles. Berlin, Heidelberg: Springer; 2016. pp: 221–2. [
DOI]
7. Intellectual property (TRIPS) – fact sheet – pharmaceuticals – contents [Internet]. WTO. 2006. Available from: [
Article]
8. Nain B. Impact of Trips Agreement on Developing Countries. SSRN Journal. 2006. [
Article]
9. Abbasi M, Khakpour M, Foroghi M. Criminal Responsibility and mental disorder Base on DSM-IV. Iranian Journal of Medical Law. 2012;6(23):13–43. [Persian] [
Article]
10. Javid E, Niavarani S. The Scope of the Right to Health in International Human Rights Law. Public Law Researsh. 2014;15(41):47–70. [Persian] [
Article]
11. Shahabedin A. Intellectual Property and Sustainable Development. Tehran: Adak Publication; 2012, pp:61. [Persian]